Literature DB >> 17451769

Silencing and complementation of reovirus core protein mu2: functional correlations with mu2-microtubule association and differences between virus- and plasmid-derived mu2.

John Carvalho1, Michelle M Arnold, Max L Nibert.   

Abstract

A low-copy component of mammalian reovirus particles is mu2, an 83-kDa protein encoded by the M1 viral genome segment and packaged within the viral core. Previous studies have identified mu2 as a nucleoside triphosphate phosphohydrolase (NTPase) as well as an RNA 5'-triphosphate phosphohydrolase (RTPase), putatively involved in reovirus RNA synthesis and/or 5'-capping. Other studies have identified mu2 as a microtubule-binding protein, which also associates with the viral factory matrix protein muNS and thereby anchors the factories to cellular microtubules during infections by most reovirus strains. To extend studies of mu2 functions during infection, we tested a small interfering RNA (siRNA) directed against the M1 plus-strand RNAs of reovirus strains Type 1 Lang (T1L) and Type 3 Dearing (T3D). The siRNA strongly suppressed mu2 expression by either strain and reduced infectious yields in a strain-dependent manner. This first strain difference was genetically mapped to the M1 genome segment and tentatively assigned to a single mu2 sequence polymorphism, Pro/Ser208, which also determines a T1L-T3D strain difference in microtubule association. The siRNA-based defect in mu2 expression was rescued by plasmids, containing silent mutations in the siRNA-targeted sequence, which encoded either T1L or T3D mu2, but the growth defect was rescued only by T1L mu2. This second strain difference was also mapped to Pro/Ser208, in that swapping this one residue between T1L and T3D mu2 reversed the rescue phenotypes. Thus, the T1L-T3D strain difference in mu2-microtubule association was correlated not only with the extent of reduction in infectious yields by the siRNA but also with the extent of rescue by plasmid-derived mu2. In addition, the rescue capacity of T1L mu2 was abrogated by nocodazole treatment, providing independent evidence for the importance of mu2-microtubule association in plasmid-based rescue. In two separate cases, the results revealed functional differences between virus- and plasmid-derived mu2. Ala substitutions within the NTP-binding motif of T1L mu2 also abrogated its rescue capacity, suggesting that the NTPase or RTPase activity of mu2 is additionally required for effective viral growth.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17451769      PMCID: PMC2486448          DOI: 10.1016/j.virol.2007.03.037

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  50 in total

1.  Reovirus sigma NS protein localizes to inclusions through an association requiring the mu NS amino terminus.

Authors:  Cathy L Miller; Teresa J Broering; John S L Parker; Michelle M Arnold; Max L Nibert
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

2.  Reovirus nonstructural protein mu NS recruits viral core surface proteins and entering core particles to factory-like inclusions.

Authors:  Teresa J Broering; Jonghwa Kim; Cathy L Miller; Caroline D S Piggott; Jason B Dinoso; Max L Nibert; John S L Parker
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

3.  Conserved sequence motifs for nucleoside triphosphate binding unique to turreted reoviridae members and coltiviruses.

Authors:  Max L Nibert; Jonghwa Kim
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

4.  Reovirus core protein mu2 determines the filamentous morphology of viral inclusion bodies by interacting with and stabilizing microtubules.

Authors:  John S L Parker; Teresa J Broering; Jonghwa Kim; Darren E Higgins; Max L Nibert
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

5.  Reovirus sigma NS and mu NS proteins form cytoplasmic inclusion structures in the absence of viral infection.

Authors:  Michelle M Becker; Timothy R Peters; Terence S Dermody
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

6.  Mammalian reovirus nonstructural protein microNS forms large inclusions and colocalizes with reovirus microtubule-associated protein micro2 in transfected cells.

Authors:  Teresa J Broering; John S L Parker; Patricia L Joyce; Jonghwa Kim; Max L Nibert
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

7.  Rotavirus replication: plus-sense templates for double-stranded RNA synthesis are made in viroplasms.

Authors:  Lynn S Silvestri; Zenobia F Taraporewala; John T Patton
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

8.  Increased ubiquitination and other covariant phenotypes attributed to a strain- and temperature-dependent defect of reovirus core protein mu2.

Authors:  Cathy L Miller; John S L Parker; Jason B Dinoso; Caroline D S Piggott; Michel J Perron; Max L Nibert
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  Nucleoside and RNA triphosphatase activities of orthoreovirus transcriptase cofactor mu2.

Authors:  Jonghwa Kim; John S L Parker; Kenneth E Murray; Max L Nibert
Journal:  J Biol Chem       Date:  2003-11-12       Impact factor: 5.157

10.  Inhibition of reovirus by mycophenolic acid is associated with the M1 genome segment.

Authors:  Laura L Hermann; Kevin M Coombs
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

View more
  11 in total

1.  A post-entry step in the mammalian orthoreovirus replication cycle is a determinant of cell tropism.

Authors:  Laura S Ooms; Takeshi Kobayashi; Terence S Dermody; James D Chappell
Journal:  J Biol Chem       Date:  2010-10-26       Impact factor: 5.157

2.  Sequestration of free tubulin molecules by the viral protein NSP2 induces microtubule depolymerization during rotavirus infection.

Authors:  Davy Martin; Mariela Duarte; Jean Lepault; Didier Poncet
Journal:  J Virol       Date:  2009-12-23       Impact factor: 5.103

3.  Engineering recombinant reoviruses with tandem repeats and a tetravirus 2A-like element for exogenous polypeptide expression.

Authors:  Aleksander A Demidenko; Joseph N Blattman; Negin N Blattman; Philip D Greenberg; Max L Nibert
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-29       Impact factor: 11.205

4.  Characterization of a Replicating Mammalian Orthoreovirus with Tetracysteine-Tagged μNS for Live-Cell Visualization of Viral Factories.

Authors:  Luke D Bussiere; Promisree Choudhury; Bryan Bellaire; Cathy L Miller
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

5.  The reovirus μ2 C-terminal loop inversely regulates NTPase and transcription functions versus binding to factory-forming μNS and promotes replication in tumorigenic cells.

Authors:  Wan Kong Wynton Yip; Francisca Cristi; Georgi Trifonov; Nashae Narayan; Mark Kubanski; Maya Shmulevitz
Journal:  J Virol       Date:  2021-03-03       Impact factor: 5.103

6.  Identification of functional domains in reovirus replication proteins muNS and mu2.

Authors:  Takeshi Kobayashi; Laura S Ooms; James D Chappell; Terence S Dermody
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

7.  Reovirus mu2 protein inhibits interferon signaling through a novel mechanism involving nuclear accumulation of interferon regulatory factor 9.

Authors:  Jennifer Zurney; Takeshi Kobayashi; Geoffrey H Holm; Terence S Dermody; Barbara Sherry
Journal:  J Virol       Date:  2008-12-24       Impact factor: 5.103

8.  Formation of the factory matrix is an important, though not a sufficient function of nonstructural protein mu NS during reovirus infection.

Authors:  Michelle M Arnold; Kenneth E Murray; Max L Nibert
Journal:  Virology       Date:  2008-04-18       Impact factor: 3.616

9.  Virus-mediated compartmentalization of the host translational machinery.

Authors:  Emily A Desmet; Lynne J Anguish; John S L Parker
Journal:  mBio       Date:  2014-09-16       Impact factor: 7.867

10.  Dissection of mammalian orthoreovirus µ2 reveals a self-associative domain required for binding to microtubules but not to factory matrix protein µNS.

Authors:  Catherine Eichwald; Jonghwa Kim; Max L Nibert
Journal:  PLoS One       Date:  2017-09-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.